title: [Is the use of placebo as control group in MS drug trials still appropriate?].
authors: St. Josef-Hospital Bochum, Neurologische Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland, aiden.haghikia@rub.de.
authors: A
authors: A
authors: Haghikia
authors: R
authors: R
authors: Gold
mesh_terms: D005858:Germany; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care / Q000941:ethics* / Q000379:methods*; D015990:Placebo Effect; D016032:Randomized Controlled Trials as Topic / Q000941:ethics* / Q000379:methods
chemical_list: D007166:Immunosuppressive Agents